Takeda Oncology
Caroline Ferrari is an experienced professional in program management, currently serving as Associate Director of Program Management at Takeda Oncology since June 2015. Prior roles at Takeda include Senior Program Manager, Project Manager in GMA Operations, Associate Project Manager, and Senior Administrative Associate. Prior to joining Takeda, Caroline worked as an Executive Assistant at Heidrick & Struggles and as a Program Administrator at Suffolk University. Additionally, experience includes serving as an Administrative Coordinator/Spanish & English Client Services Coordinator at WIDE World at the Harvard Graduate School of Education. Caroline holds a Bachelor of Arts degree in Spanish and German Languages and Literatures from Bowdoin College, complemented by studies at Universidad Complutense de Madrid and Humboldt-Universität zu Berlin. Caroline graduated from Ransom Everglades High School in 2006.
This person is not in any teams
This person is not in any offices
Takeda Oncology
20 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.